Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0003 (-75.00%)
Jul 30, 2026, 4:00 PM EST

Syros Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
020373202497293
Market Cap Growth
-90.91%179.01%-64.05%-59.37%69.48%56.45%
Enterprise Value
-153-108101451206
Last Close Price
0.007.793.5932.60108.5069.10

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
0.0120.394.888.6032.93147.97
PB Ratio
0.0012.160.572.375.493.70
P/TBV Ratio
-12.160.572.375.493.70

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
-15.38-4.2929.86104.14

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-5.413.730.500.770.730.33
Net Debt / Equity Ratio
-0.17-4.65-1.09-0.92-1.19-0.83
Net Debt / EBITDA Ratio
-0.020.621.120.811.360.87
Net Debt / FCF Ratio
-0.020.701.120.781.780.90
Asset Turnover
0.000.050.070.120.080.02
Quick Ratio
2.053.806.634.236.164.75
Current Ratio
2.253.956.874.346.244.87
Return on Equity (ROE)
-776.96%-227.95%-88.90%-98.49%-99.02%-95.63%
Return on Assets (ROA)
-59.88%-38.32%-36.95%-31.37%-28.32%-37.85%
Return on Capital Employed (ROCE)
-197.00%-96.20%-59.10%-65.70%-44.60%-61.50%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Jul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-3645732.39%-81.23%-130.36%-42.86%-16.91%-25.72%
FCF Yield
-3729183.75%-54.29%-171.19%-49.91%-12.21%-24.86%
Buyback Yield / Dilution
-31.77%-124.24%-102.00%-35.79%-14.49%-23.17%